Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Gartner, Eli Lilly, And The Trade Desk Are Among Top 10 Large Cap Losers Last Week (August 4-August 8): Are The Others In Your Portfolio?

Author: Nabaparna Bhattacharya | August 10, 2025 02:41pm

These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio?

  1. The Trade Desk, Inc. (NASDAQ:TTD) stock lost 37.87% last week after the company reported second-quarter financial results. Multiple analysts lowered price forecast on the stock.
  2. Figma, Inc. (NYSE:FIG) stock fell 21.88% last week amid continued volatility following its recent IPO.
  3. Gartner, Inc. (NYSE:IT) stock decreased 30.82% last week after the company issued soft FY25 guidance.
  4. Fortinet, Inc. (NASDAQ:FTNT) stock slumped 23.95% last week after releasing second-quarter results. Multiple analysts lowered the price forecast on the stock.
  5. Super Micro Computer, Inc. (NASDAQ:SMCI) stock declined 23.28% last week after the company reported worse-than-expected fourth-quarter financial results, issued first-quarter EPS and adjusted EPS guidance below estimates, and cut its FY26 sales guidance.
  6. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stock fell 21.23% last week following the release of its second-quarter financial results. The company announced results from its Vx-993 Phase 2 trial. Additionally, several firms cut their respective price forecasts on the stock.
  7. Twilio Inc. (NYSE:TWLO) stock slumped 19.58% last week after the company issued third-quarter guidance below estimates.
  8. Snap Inc. (NYSE:SNAP) stock fell 18.88% last week after the company announced a $500 million notes offering.
  9. Eli Lilly and Company (NYSE:LLY) stock decreased 17.67% last week after the company reported second-quarter results. Also, the firm announced topline results from the Phase 3 ATTAIN-1 trial evaluating orforglipron in adults with obesity.
  10. Venture Global, Inc. (NYSE:VG) stock slumped 18.10% last week. The company received DOE approval to increase Calcasieu Pass LNG capacity from 12.0 to 12.4 million tonnes per annum.

Read Next:

Posted In: FIG FTNT IT LLY SMCI SNAP TTD TWLO VG VRTX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist